Correlation Between Telomir Pharmaceuticals, and Aura Biosciences

Can any of the company-specific risk be diversified away by investing in both Telomir Pharmaceuticals, and Aura Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telomir Pharmaceuticals, and Aura Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telomir Pharmaceuticals, Common and Aura Biosciences, you can compare the effects of market volatilities on Telomir Pharmaceuticals, and Aura Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telomir Pharmaceuticals, with a short position of Aura Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telomir Pharmaceuticals, and Aura Biosciences.

Diversification Opportunities for Telomir Pharmaceuticals, and Aura Biosciences

-0.37

Correlation Coefficient

Telomir Pharmaceuticals,  Aura Biosciences

Very good diversification

The 3 months correlation between Telomir and Aura is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Telomir Pharmaceuticals, Commo and Aura Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aura Biosciences and Telomir Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telomir Pharmaceuticals, Common are associated (or correlated) with Aura Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aura Biosciences has no effect on the direction of Telomir Pharmaceuticals, i.e., Telomir Pharmaceuticals, and Aura Biosciences go up and down completely randomly.

Pair Corralation between Telomir Pharmaceuticals, and Aura Biosciences

Given the investment horizon of 90 days Telomir Pharmaceuticals, Common is expected to generate 2.23 times more return on investment than Aura Biosciences. However, Telomir Pharmaceuticals, is 2.23 times more volatile than Aura Biosciences. It trades about 0.0 of its potential returns per unit of risk. Aura Biosciences is currently generating about -0.03 per unit of risk. If you would invest  600.00  in Telomir Pharmaceuticals, Common on September 18, 2024 and sell it today you would lose (105.50) from holding Telomir Pharmaceuticals, Common or give up 17.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Telomir Pharmaceuticals, Commo  vs.  Aura Biosciences

Telomir Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Telomir Pharmaceuticals, is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Aura Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aura Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Aura Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Telomir Pharmaceuticals, and Aura Biosciences

The main advantage of trading using opposite Telomir Pharmaceuticals, and Aura Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telomir Pharmaceuticals, position performs unexpectedly, Aura Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aura Biosciences will offset losses from the drop in Aura Biosciences' long position.

The idea behind Telomir Pharmaceuticals, Common and Aura Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.